TORONTO--(BUSINESS WIRE)--Oct 18, 2023--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation therapies targeting pain and inflammation, is pleased to announce the initiation of the ...
HOUSTON--(BUSINESS WIRE)--Oct 17, 2023--Diakonos Oncology Corporation (鈥淒iakonos鈥�), a clinical stage immuno-oncology company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the Company蘑菇视频 unique dendritic cell vaccine, DOC1021. The ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--Oct 17, 2023--<a ...
TOKYO--(BUSINESS WIRE)--Oct 17, 2023--Skeletal muscle fibrosis which leads to locomotor dysfunction in Duchenne Muscular Dystrophy (DMD) could be significantly reduced by oral consumption of Neu-REFIX beta 1,3-1,6 glucans alone for 45 days without any other drugs, in MDX mice model of DMD. This ...
DUBLIN--(BUSINESS WIRE)--Jul 21, 2023--The <a ...
ROOT, Switzerland--(BUSINESS WIRE)--Jul 21, 2023--Novocure (NASDAQ: NVCR) today announced the results of a pre-specified interim analysis for the phase 3 PANOVA-3 clinical trial evaluating the safety and efficacy of Tumor Treating Fields (TTFields) therapy together with nab-paclitaxel and ...
